29 August 2018
Visiongain’s new report Global Cardiovascular Devices Market Forecast 2017-2027: Diagnostics & Monitoring, Surgical, ECG, Holter Monitors, Event Monitors, Implantable Loop Recorders, Ultrasound, Echocardiograms, Doppler Foetal Monitors, CT-Scan, PET/SPECT, Cardiac CT MRI, Stents, Valves, Pacemakers, Occlusion Devices, Cannulae, Electrosurgical Devices, Accessories/Consumables, Guidewires, Catheters indicates that the global cardiovascular devices market will see $54.2bn in spending in 2021.
The global cardiovascular devices market was valued at $40.05bn in 2016. Visiongain estimates that this market will grow at a CAGR of 6.4% in the first half of the forecast period and reach $54.22bn in 2021.This market is estimated to grow faster in the second half of the forecast period, growing at a CAGR of 7.1% and reach $81.38bn in 2027. The global cardiovascular devices market is estimated to grow at a CAGR of 6.7% from 2017 to 2027.
The lead analyst of the report said: “The global cardiovascular devices market is anticipated to show considerable growth during the forecast period. Cardiovascular diseases are the leading cause of deaths in the world. High prevalence of cardiovascular diseases (CVD), technical advancement and rising awareness regarding early diagnosis and prevention solutions are some of the prime factors impacting the growth of the global cardiovascular devices market positively.
On the other hand, requirement of skilled professionals for usage of commercially available technologies such as PET/SPECT, placing implantable loop recorder and stents is hindering the growth of the market.”
The 142 page report contains 130 charts (tables and figures) that add visual analysis in order to explain the developing trends within the Global Cardiovascular Devices Market. Visiongain provides revenue forecasts for the period 2017-2027 as well as qualitative analyses for the leading segments of this market: Surgical Devices as well as Diagnostics and Monitoring Devices.
The 142 page report offers market forecasts and analysis for 13 leading national markets. In addition, the report contains a dedicated leading companies’ chapter covering companies leading the field in the cardiovascular devices market.
The Global Cardiovascular Devices Market Forecast 2017-2027: Diagnostics & Monitoring, Surgical, ECG, Holter Monitors, Event Monitors, Implantable Loop Recorders, Ultrasound, Echocardiograms, Doppler Foetal Monitors, CT-Scan, PET/SPECT, Cardiac CT MRI, Stents, Valves, Pacemakers, Occlusion Devices, Cannulae, Electrosurgical Devices, Accessories/Consumables, Guidewires, Catheters report will be of value to anyone who wants to better understand the cardiovascular devices market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the cardiovascular devices industry.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.
21 July 2021
Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.
20 July 2021
Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.
14 July 2021
Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.